Skip to content

Full-spectrum Endoscopy in Colorectal Cancer Screening

Impact of Full-spectrum Endoscopy in Colorectal Cancer Screening: Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02812550
Enrollment
249
Registered
2016-06-24
Start date
2015-05-31
Completion date
2016-06-30
Last updated
2016-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

full-spectrum endoscopy, polyp detection rate, colorectal cancer, colorectal screening, adenoma detection rate, endoscopic innovations

Brief summary

The purpose of this study is to compare the adenoma detection rates of full-spectrum endoscopy versus standard forward-viewing colonoscopy in colorectal cancer screening programme.

Detailed description

Colorectal cancer is the third most common neoplasia and the second leading cause of cancer death in West countries. Colonoscopy is the gold standard for prevention of colorectal cancer disease. Screening for colorectal cancer with biennial faecal occult blood testing is a widely used strategy followed by colonoscopy for those with a positive test. Colonoscopy identifies polyps during the procedure as well as polyp removal in order to prevent progression to cancer. Although, interval cancer appears after a colonoscopy because of 22-28% of polyp missed rates. Advanced Technology may improve adenoma detection rates so decrease interval cancer and reduce mortally. Full-spectrum endoscopy with 330º angle vision decrease adenoma miss rate in general population. The investigators conducted a randomized trial in patients from colorectal cancer screening programme (aged 50-69 years) after faecal immunological test positive. One arm the colonoscopy is performed with standard forward view colonoscopy (170º angle view) and the other arm is performed with full-spectrum endoscopy (EndoChoice) (330º angle view)

Interventions

endoscopy performed with a standard forward view colonoscopy or with full-spectrum endoscopy

Sponsors

Hospital del Rio Hortega
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* patient referred for colorectal cancer screening with positive fecal inmunological test. * Age between 50 and 69 years

Exclusion criteria

* history of colonic resection, * high risk for colorectal cancer like family history of colorectal cancer o polyposis syndrome, * inflammatory bowel disease, * patients with lower gastrointestinal bleeding symptoms, * acute diverticulitis, * colonic strictures, * poor bowel preparation (Boston scale less than 5 points)

Design outcomes

Primary

MeasureTime frameDescription
adenoma detection rate in the two different colonoscopiesone weeknumber of colonoscopies at wich one or more histologically confirmed adenomas were found divided by the total number of colonoscopies performed in the same time period.

Secondary

MeasureTime frameDescription
total procedure time in each groupone weektime since the begining of the procedure till is totally finish
Adverse eventsone weekAny inmediatly complication
advance adenoma rate in each groupone week10mm or greater in size, villous component or high grade dysplasia
time to caecal intubation in each groupone weektime to reach appendicular orifice
polyp retrieval rate in each groupone weekproportion of resected polyps that were retrieved and sent for histologically analysis
caecal intubation rate in each groupone weekproportion of all colonoscopic procedures in which the caecum, terminal ileum was reached
colonoscopy withdrawal timeone weekaverage time taken withdraw the colonoscope from the caecal pole to the anus.
polyp detection rate in right and left colon in each groupone week

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026